Showing results (41-50 of 242) with videos related to
Sort By:
Pageof 25
British Journal of Cancer|June 1, 1993
Cellular accumulation of the anticancer agent cisplatin: a reviewD P Gately, S B HowellClinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
The role of DNA mismatch repair in drug resistanceD Fink, S Aebi, S B HowellActa Medica Austriaca|January 1, 1989
Novel approaches to intraperitoneal drug deliveryS B Howell, S Kirmani, R GoelEuropean Journal of Cancer & Clinical Oncology|September 1, 1985
Nephrotoxicity of high-dose intracavitary cisplatin with intravenous thiosulfate protectionM Markman, S Cleary, S B HowellBlood|March 1, 1980
Thymidine as a chemotherapeutic agent: sensitivity of normal human marrow, peripheral blood T cells, and acute nonlymphocytic leukemiaS B Howell, R Taetle, J MendelsohnJournal of Cellular Physiology|June 1, 1994
Cisplatin sensitivity correlates with its ability to cause cell cycle arrest via a wee1 kinase-dependent pathway in Schizosaccharomyces pombeF Thiebaut, R Enns, S B HowellCancer Research|April 1, 1979
Cytokinetic comparison of thymidine and leucovorin rescue of marrow in humans after exposure to high-dose methotrexateS B Howell, A Krishan, E FreiMolecular Biology & Medicine|October 1, 1987
Evidence against ras activation in human ovarian carcinomasM Haas, J Isakov, S B HowellCancer Chemotherapy and Pharmacology|January 1, 1989
Pharmacologic basis for the use of dipyridamole to increase the selectivity of intraperitoneally delivered methotrexateR Goel, R Sanga, S B HowellMolecular Pharmacology|November 1, 1996
Isolation and characterization of a cisplatin-resistant strain of Schizosaccharomyces pombeP Perego, G Jimenez, S B HowellPageof 25